• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    Vertex Pharmaceuticals Incorporated (VRTX)

    133.06 Up 1.09(0.83%) Nov 27, 1:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:145.68
    Median Target:145.00
    High Target:180.00
    Low Target:110.00
    No. of Brokers:19

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 28, 2015ArgusUpgradeHoldBuy
    Jan 29, 2015Maxim GroupDowngradeBuyHold
    Jan 29, 2015NeedhamDowngradeBuyHold
    Nov 6, 2014CRT CapitalInitiated Buy
    Jun 25, 2014H.C. WainwrightDowngradeBuyNeutral
    Jan 6, 2014UBSUpgradeNeutralBuy
    Oct 30, 2013Summer Street ResearchDowngradeBuyNeutral
    Aug 22, 2013OppenheimerInitiated Outperform
    Apr 19, 2013Canaccord GenuityUpgradeHoldBuy
    Apr 10, 2013Chardan Capital MarketsInitiated Buy

    More Upgrades & Downgrades for VRTX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy5555

    Data provided by Thomson/First Call

    Currency in USD.